Q3 2016 Holdings
Filed 2016-11-14 | 8 holdings | $750.7M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2017-05-22) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Abbvie Inc(ABBV) | Common | 00287Y109 | $695.6M | 11,029,800 | 92.7% |
| Biogen Inc(BIIB) | Common | 09062X103 | $53.4M | 170,430 | 7.1% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $617.4K | 10,301,751 | 0.1% |
| Reynolds American Inc | Common | 761713106 | $358.7K | 7,608,324 | 0.0% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $355.0K | 7,549,033 | 0.0% |
| Theravance Biopharma Inc(TBPH) | Common | G8807B106 | $340.9K | 9,407,137 | 0.0% |
| Gilead Sciences Inc(GILD) | Common | 375558103 | $38.5K | 486,800 | 0.0% |
| Northwest Biotherapeutics Inc(NWBO) | Common | 66737P600 | $14.1K | 25,915,937 | 0.0% |